TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced a strategic partnership with Quarks Technosoft, a leading digital engineering and quality consulting firm, to redefine how enterprises approach software testing in the age of AI-driven development. As organizations increasingly adopt AI to generate code at unprecedented speed, traditional testing models are emerging as the primary constraint to innovation. This partnership br...
The Japan Prize Foundation (President: Ryozo Nagai) held an award ceremony on Tuesday, April 14, at the New National Theatre, Tokyo in Tokyo's Shibuya Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the global scientific and technological fields and who have contributed significantly to realizing peace and prosperity for all humanity. Cynthia Dwork, Ph.D. (USA), the winner in the field of Electronics, Information, and Communication, and Shizuo ...
AngloGold Ashanti Holdings plc (the “Offeror”), a company incorporated under the laws of the Isle of Man, announces today the pricing of the previously announced capped cash tender offers that the Offeror commenced on March 30, 2026 (the “Offers”), for up to $650,000,000 aggregate purchase price (exclusive of Accrued Interest), for part of its outstanding (i) $750,000,000 3.375% notes due 2028 (the “2028 Notes”), (ii) $700,000,000 3.750% notes due 2030 (the “2030 Notes”) and (iii) $300,000,000 ...
Brenus Pharma announced that new first‑in‑human data will be presented at the AACR Annual Meeting 2026 (April 17–22, San Diego, California). The company continues to advance its lead candidate, STC-1010, a next generation in vivo allogeneic immunotherapy built on the Stimulated Ghost Cells (SGC) technology. The poster will provide a translational overview demonstrating how STC-1010 is administrated in microsatellite‑stable colorectal cancer (MSS CRC), a setting resistant to standards immunoth...
IFF (NYSE: IFF) today announced that it will release its first quarter 2026 earnings results following the market close on Tuesday, May 5, 2026. The management team will host a live webcast on Wednesday, May 6, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available ...
GoldenTree Asset Management (“GoldenTree”), a global asset management firm with approximately $70 billion in assets under management, today announced the hiring of Ken Takao as Principal and Head of Business Development in Japan. The newly created role is based in GoldenTree’s Tokyo office. Mr. Takao will also serve as a Representative in Japan, and will report to Kathy Sutherland, GoldenTree’s CEO. He brings more than two decades of leadership experience and deep relationships in Japan to Gold...
Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the PrepQuant™ System, a novel sample preparation platform that integrates nucleic acid extraction, concentration, and quantification with a single automated instrument. This innovative system is designed to standardize sample preparation and simplify pre-analytical workflows to reduce costs and eliminate a primary source of inconsistency in molecular testing. D...
FPT has signed a landmark agreement to provide Microsoft 365 (M365) licenses to Chugoku Electric Power Group - one of Japan’s ten largest regional power utilities, ranked sixth by electricity sales. This milestone underscores FPT’s leadership in Japan’s technology sector and its pivotal role in driving innovation and advancing the digital transformation of the Hiroshima-headquartered group. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho...
Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that at ESCMID Global 2026, to be held from 17 to 21 April 2026, it will present a total of ten studies on its novel β-lactamase inhibitor nacubactam (development code: OP0595), for which a manufacturing and marketing authorisation application is under review in Japan. The presentations include results from Integral-2, an international, multicentre Phase III clinical t...
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense management platform, today announced it has been selected by Opella to manage its global travel and expense programme. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415188706/en/Self-care company aims to simplify employee T&E experience and targets cost savings with AI-powered platform “Navan provides our teams with an easy-to-use tool that removes the c...